Bolt Biotherapeutics, Inc. (BOLT) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US0977022039
Bolt Biotherapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 7.70 m USD |
| Operating income | -36.11 m USD |
| EBIT | -33.38 m USD |
| Net income | -33.38 m USD |
| Diluted EPS – continuing operations | -17.85 USD |
Full history since 2018, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Bolt Biotherapeutics, Inc.
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer. The company's pipeline products include BDC-4182, a next-generation Boltbody ISAC that targets the tumor-associated antigen claudin 18.2 for the treatment of gastric/gastroesophageal junction cancer, pancreatic cancer, and other tumor types; BDC-3042, a dectin-2 agonist antibody program for the treatment of non-small cell lung cancer, melanoma, and other solid tumors; CEA ISAC, a Boltbody ISAC targeting carcinoembryonic antigen cell adhesion molecule 5 for the treatment of solid tumors, including colorectal, non-small cell lung, pancreatic, and breast; and PD-L1 ISAC, a novel human anti-PD-L1 antibody conjugated to a next-generation TLR7/8 agonist payload via a non-cleavable linker to target both tumor and immune cells for the treatment of tumor regression and immunological memory. The company has collaboration agreements with Toray Industries, Genmab A/S, and Innovent Biologics, Inc.; and a license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.
More stocks
- AmBase Corp (ABCP)
- Sphere 3D Corp. (ANY)
- MERCER INTERNATIONAL INC. (MERC)
- Beeline Holdings, Inc. (BLNE)
- Sentinel Holdings Ltd. (SNTL)
- Vivid Seats Inc. (SEAT)
- Tvardi Therapeutics, Inc. (TVRD)
- TAO Synergies Inc. (TAOX)
- T-REX Acquisition Corp. (TRXA)
- ACTUATE THERAPEUTICS, INC. (ACTU)
- ClearSign Technologies Corp (CLIR)
- SANUWAVE Health, Inc. (SNWV)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.